Kallikrein 5 Antikörper (N-Term)
Kurzübersicht für Kallikrein 5 Antikörper (N-Term) (ABIN634928)
Target
Alle Kallikrein 5 (KLK5) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- KLK5 antibody was raised against the N terminal of KLK5
-
Aufreinigung
- Affinity purified
-
Immunogen
- KLK5 antibody was raised using the N terminal of KLK5 corresponding to a region with amino acids CDHPSNTVPSGSNQDLGAGAGEDARSDDSSSRIINGSDCDMHTQPWQAAL
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
KLK5 Blocking Peptide, (ABIN937048), is also available for use as a blocking control in assays to test for specificity of this KLK5 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KLK5 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Kallikrein 5 (KLK5)
-
Andere Bezeichnung
- KLK5
-
Hintergrund
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers.
-
Molekulargewicht
- 25 kDa (MW of target protein)
-
Pathways
- Komplementsystem, Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-